Galera Therapeutics, Inc. Business Finance Contracts & Agreements
14 Contracts & Agreements
- Investor Rights Agreements (2 contracts)
- Purchase Agreements (4)
- Registration Rights Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (1)
- Warrant Agreements (4)
- Form of Registration Rights Agreement (Filed With SEC on December 31, 2024)
- Securities Purchase Agreement, dated as of December 30, 2024, by and among Galera and each purchaser identified on Annex A thereto (Filed With SEC on December 31, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on December 31, 2024)
- Form of Securities Purchase Agreement dated February 15, 2023 by and among the Company and the purchasers named therein (Filed With SEC on February 16, 2023)
- Form of Warrant (Filed With SEC on February 16, 2023)
- Warrant Purchase Agreement, dated May 11, 2020, by and between Galera Therapeutics, Inc. and Clarus IV Galera Royalty AIV, L.P (Filed With SEC on August 10, 2020)
- Amendment No. 1 to Amended and Restated Purchase and Sale Agreement, dated May 11, 2020, by and between Galera Therapeutics, Inc. and Clarus IV Galera Royalty AIV, L.P (Filed With SEC on August 10, 2020)
- Form of Warrant to Purchase Stock, dated May 11, 2020, issued by Galera Therapeutics, Inc. to Clarus IV Galera Royalty AIV, L.P., together with a schedule of warrantholders (Filed With SEC on August 10, 2020)
- Galera Therapeutics, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on October 28, 2019)
- Second Amended and Restated Investors Rights Agreement, dated as of August 30, 2018, by and among Galera Therapeutics, Inc. and the investors party thereto (Filed With SEC on October 28, 2019)
- Form of Certificate of Common Stock (Filed With SEC on October 28, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 28, 2019)
- Amended and Restated Purchase and Sale Agreement, dated as of November 14, 2018, by and among Galera Therapeutics, Inc. and Clarus IV Galera Royalty AIV, L.P., Clarus IV-A, L.P.,... (Filed With SEC on October 11, 2019)
- Second Amended and Restated Investors Rights Agreement, dated as of August 30, 2018, by and among Galera Therapeutics, Inc. and the investors party thereto (Filed With SEC on October 11, 2019)
